Navigation Links
Lilly Reports Solid Second-Quarter Results
Date:7/24/2008

echnology company focused on drug discovery and development in the area of oncology. The transaction is expected to close in the second half of 2008, contingent upon approval by SGX shareholders, clearance under the Hart-Scott-Rodino Antitrust Improvements Act and certain other closing conditions. Upon the closing of the transaction in 2008, Lilly expects to incur a one-time charge to earnings for acquired in-process research and development, but it is premature to estimate what that charge will be.

-- The company entered into a licensing and development agreement with TransPharma Medical Ltd. related to TransPharma's ViaDerm-hPTH (1-34) product for the treatment of osteoporosis. The product, which is administered transdermally using TransPharma's proprietary technology, is currently in Phase II clinical testing.

-- The company established an arrangement with TPG-Axon Capital and NovaQuest - the partnering group of Quintiles Transnational - for the Phase III development of the company's two lead molecules for Alzheimer's disease. This arrangement provides TPG-Axon and NovaQuest with success-based milestones and royalties in exchange for funding of Phase III clinical trials for the two molecules. The arrangement also closely aligns the parties' interests to have Quintiles' experts in this therapeutic category execute Phase III trials with optimal speed. This arrangement will provide Lilly greater flexibility to direct internal resources to advance additional molecules in its pipeline.

-- The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) issued a positive opinion supporting the approval of Cymbalta for the treatment of generalized anxiety disorder (GAD).

-- The FDA approved Cymbalta for the management of fibromyalgia, a chronic widespread pain disorder.

-- The company submitted a supplemental New Drug Application (sNDA) to the FDA seeking approval for a new indication for Cymbalta for t
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Lilly to Acquire SGX Pharmaceuticals
2. Lillys Connelly Appointed to the Presidents Commission on White House Fellowships
3. Lilly Employees from Nearly 50 Nations Participate in Companys First-Ever Global Day of Service
4. Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
5. Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
6. Lilly CEO Urges Policy Prescriptions to Help Ensure Public and Private Biotech Investments Generate Dividends and U.S. Job Growth
7. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
8. Lilly Reports Solid First-Quarter Results
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
11. Lilly Announces Termination of AIR Insulin Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... (PRWEB) October 22, 2014 Involution ... the release of a new infographic, Understanding Ebola ... create a beautifully designed, easy to follow informative tool ... areas of outbreak, symptoms and prevention. , "As the ... that the 2014 Ebola outbreak represents not only a ...
(Date:10/22/2014)... Rock Hill, SC (PRWEB) October 22, 2014 ... the expansion of its cardiovascular pharmacogenetics menu, which ... improved patient outcomes. With PCLS’s evidence-based results, ... individual needs and optimize their therapy, while minimizing ... , In the U.S., according to the FDA ...
(Date:10/22/2014)... 2014 Nuvilex, Inc. (OTCQB: NVLX) – According ... worldwide are living with diabetes, with  that number expected ... global market for diabetes treatments is approximately $500 billion.  ... died from pancreatic cancer.  Pancreatic cancer is the fourth ... the United States , and according ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
Breaking Biology Technology:Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3
... Chromatography and Mass Spectrometry Application Note , ... Structure Elucidation Metabolite ID Mass Frontier , ... Introduction , ... plays a crucial role throughout its development. In the early discovery phase, ...
... and Mass Spectrometry Application Note , ... Thermo Electron Corporation, Somerset, NJ, USA , ... Acrylamide has been identified as a ... common industrial chemical, but acrylamide was recently discovered to be present at ...
... Gargi Choudhary, Tania A. Sasaki, and ... Chromatography and Mass Spectrometry ... Introduction , Ion trap mass ... MS n such as for structural elucidation and identification of ...
Cached Biology Technology:Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 2Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 3Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 4Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 5Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 6Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 7Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 8Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 9Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 10Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 2Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 3Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 4Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 5Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 6Sensitivity and Quantitation using a Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer 2Sensitivity and Quantitation using a Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer 3
(Date:10/16/2014)... SHELTON, Conn. , October 16, 2014 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... present its leading edge technologies including Wocket™, the Smart ... Review® (FiRe) Conferenece. FiRe is a leading global conference ... Hosted by Mark Anderson , founder ...
(Date:10/15/2014)... book ,Models of Life, is a non-traditional biophysics textbook ... The book is a journey of discovery into biological ... life and biological regulation. It is about how our ... communication between the billions of cells in an organism. ... relationships between principles, which can be found on both ...
(Date:10/15/2014)... bacterial pneumonia in female mice to an enzyme activated ... naturally more resistant to respiratory infections than males. Now, ... resistance to bacterial pneumonia in female mice is linked ... also show that this enzyme is ultimately activated by ... The team, lead by Professor Lester Kobzik at the ...
Breaking Biology News(10 mins):NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3New book about life as seen from physics 2
... Vincetoxicum rossicum ) is an exotic plant originating ... increasingly invasive in southern Ontario, Canada. It has been ... in open fields, forest edges and understories, parks, road ... for light by forming large and dense stands that ...
... Crusafont Catalan Palaeontology Institute has for the first time documented ... Narg archaeological site in Lleida, Spain. Up until now, only ... region. , The archaeological site in Coll de Narg containing ... the town that bears the same name in the province ...
... Alex Pyron,s expertise is in family trees. Who is related ... they are now. But not for humans: reptiles. In ... the island led him to confirm the identity of 60 ... an author on snakes and expert on amphibians and reptiles, ...
Cached Biology News:A European invader outcompetes Canadian plants even outside its usual temperature range 24 dinosaur egg species identified in Lleida 2Sri Lankan snake study reveals new species, rich biodiversity in island country 2
Mouse monoclonal antibody raised against a partial recombinant MYO7A. NCBI Entrez Gene ID = MYO7A...
... Cell Lines ,High Quality, Functionally-Validated, Ion Channel ... known for having a critical role in ... a key function in pain, CNS and ... have been investigated in therapeutic areas, such ...
... ,High Quality, Functionally-Validated, Ion Channel Cell Lines ... having a critical role in nerve and ... function in pain, CNS and the heart. ... investigated in therapeutic areas, such as neuropathic ...
Mouse monoclonal antibody raised against a partial recombinant ENTPD5. NCBI Entrez Gene ID = ENTPD5...
Biology Products: